# Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug

> **NCT00607763** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 9 (actual)

## Conditions studied

- Invasive Candidiasis
- Esophageal Candidiasis
- Oropharyngeal Candidiasis
- Candidemia

## Interventions

- **DRUG:** Micafungin (Mycamine)

## Key facts

- **NCT ID:** NCT00607763
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-10
- **Final completion:** 2009-10
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2014-08-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00607763

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00607763, "Study of Mycamine® in Infants and Toddlers With Fungal Infections to Evaluate Safety and Blood Levels of the Drug". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00607763. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*